TRACEY HOFFMAN: Open Payments
NPI 1306148671 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 25 payments from 17 companies in 2025. Trend: 2023 $1,364 · 2024 $1,660 · 2025 $1,000
Food & beverage: $1,000
| Company | Payments | Amount |
|---|---|---|
| Novocure Inc. | 2 | $142 |
| E.R. Squibb & Sons, L.L.C. | 2 | $137 |
| Stemline Therapeutics Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 2 | $116 |
| Iovance Biotherapeutics, Inc. | 1 | $114 |
| Blue Earth Diagnostics | 3 | $68 |
| Merck Sharp & Dohme LLC | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Incyte Corporation | 1 | $25 |
Products named: Optune Gio, OPDIVO, Orserdu, Amtagvi, POSLUMA, KEYTRUDA, LUTATHERA, ORGOVYX.
Industry payments across KY — which companies pay providers there.
